Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
K M Prasanna Kumar, Manoj Chawla, Ami Sanghvi, Nadiminty G Sastry, Chaitanya Kotla, Sanjeev Phatak & Sanjay Choudhari. (2019) Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study. International Journal of General Medicine 12, pages 147-159.
Read now
Read now
Stewart B. Harris. (2016) The power of two: an update on fixed-dose combinations for type 2 diabetes. Expert Review of Clinical Pharmacology 9:11, pages 1453-1462.
Read now
Read now
Qingwei Zhao, Dongsheng Hong, Dongsheng Zheng, Yao Xiao & Baohua Wu. (2014) Risk of diarrhea in patients with type 2 diabetes mellitus treated with sitagliptin: a meta-analysis of 30 randomized clinical trials. Drug Design, Development and Therapy 8, pages 2283-2294.
Read now
Read now
André J Scheen. (2012) Saxagliptin plus metformin combination therapy. Expert Review of Endocrinology & Metabolism 7:2, pages 151-164.
Read now
Read now
Articles from other publishers (42)
Sun Ho Kim, Jung Han Kook, Dong-Wan Seo & Myung Joo Kang. (2023) The Effect of Compression Pressure on the First Layer Surface Roughness and Delamination of Metformin and Evogliptin Bilayer and Trilayer Tablets. Pharmaceuticals 16:11, pages 1523.
Crossref
Crossref
Amod S. Patil, Anand B. Mundada, Ravindra S. Shravane, Pooja A. Mundada & Sanjay J. Surana. (2023) Normal- and reversed-phase high-performance thin-layer chromatography methods for the simultaneous determination of remogliflozin etabonate and metformin hydrochloride antidiabetic drugs in bulk and tablet formulation. JPC – Journal of Planar Chromatography – Modern TLC 36:1, pages 89-97.
Crossref
Crossref
Kumar Venkatesan, Saad M. Alshahrani, Amal M. Alsubaiyel, Maram H. Abduljabbar, Manal E. Alosaimi, Maria Grishina & Saeed Shirazian. (2023) Experimental - Theoretical approach for determination of Metformin solubility in supercritical carbon dioxide: Thermodynamic modeling. Case Studies in Thermal Engineering 41, pages 102649.
Crossref
Crossref
Yaser Mohammed Al-Worafi, Long Chiau Ming, Abdullah Ahmed Dhabali, Abdulkareem Mohammed Al-Shami & Ammar Ali Saleh Jaber. 2023. Clinical Case Studies on Medication Safety. Clinical Case Studies on Medication Safety
5
32
.
Zeeshan Mansuri, Ramkrishna Makani, Chintan Trivedi, Mahwish Adnan, Ramu Vadukapuram, John Rafael, Ashutosh Lodhi & Abhishek Reddy. (2022) The role of metformin in treatment of weight gain associated with atypical antipsychotic treatment in children and adolescents: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Psychiatry 13.
Crossref
Crossref
Ji Hoon Kim, Kyeongjin Kim & Hyo-Eon Jin. (2022) Three-Dimensional Printing for Oral Pharmaceutical Dosage Forms. Journal of Pharmaceutical Investigation 52:3, pages 293-317.
Crossref
Crossref
Abdul Mushib Ibrahim & Stephen Lawrence. (2022) Improving Diabetes Care: A Fijian Diabetes Service Improvement Study. International Journal of Chronic Diseases 2022, pages 1-9.
Crossref
Crossref
Dalal Kojok, Ghina Ghazeeri & Johnny T. Awwad. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
233
253
.
Aedrian A. Abrilla, A. Nico Nahar I. Pajes & Cecilia A. Jimeno. (2021) Metformin extended-release versus metformin immediate-release for adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice 178, pages 108824.
Crossref
Crossref
Ayesha Akram. (2021) Reactive Hypoglycemia From Metformin Immediate-Release Monotherapy Resolved by a Switch to Metformin Extended-Release: Conceptualizing Their Concentration-Time Curves. Cureus.
Crossref
Crossref
Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Bandar E. Al-Dhubiab, Katharigatta N. Venugopala & Pottathil Shinu. (2021) Development and Validation of Green UV Derivative Spectrophotometric Methods for Simultaneous Determination Metformin and Remogliflozin from Formulation: Evaluation of Greenness. International Journal of Environmental Research and Public Health 18:2, pages 448.
Crossref
Crossref
Tariq Chukir, Lindsay Mandel, Beverly G. Tchang, Nada A. Al- Mulla, Leon I. Igel, Rekha B. Kumar, Jonathan Waitman, Louis J. Aronne & Alpana P. Shukla. (2021) Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study. Obesity Research & Clinical Practice 15:1, pages 64-68.
Crossref
Crossref
Sanjeeb Kumar Kar, Susovita Khuntia & Shubhrata Nayak. (2020) Metformin related adverse events: A prospective observational study in health care centers of western Odisha. Journal of Pharmacovigilance and Drug Research 1:2, pages 32-34.
Crossref
Crossref
Mahesh Attimarad, Rafea Elamin Elgack Elgorashe, Rajasekaran Subramaniam, Mohammed Monirul Islam, Katharigatta N. Venugopala, Sreeharsha Nagaraja & Abdulmalek Ahmed Balgoname. (2020) Development and Validation of Rapid RP-HPLC and Green Second-Derivative UV Spectroscopic Methods for Simultaneous Quantification of Metformin and Remogliflozin in Formulation Using Experimental Design. Separations 7:4, pages 59.
Crossref
Crossref
Elizabeth M. Vaughan, Jaime J. Rueda, Susan L. Samson & David J. Hyman. (2020) Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications. Current Diabetes Reviews 16:8, pages 851-858.
Crossref
Crossref
Chiamaka Esther Amaefule, Angeliki Bolou, Zoe Drymoussi, Francisco Jose Gonzalez Carreras, Maria del Carmen Pardo Llorente, Doris Lanz, Julie Dodds, Lorna Sweeney, Elena Pizzo, Maria D’Amico, Amy Thomas, James Heighway, Jahnavi Daru, Soha Sobhy, John Robson, Anita Sanghi, Javier Zamora, Angela Harden, Graham Hitman, Khalid Khan, Teresa Pérez, Mohammed SB Huda & Shakila Thangaratinam. (2020) Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trialOptimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA). BMJ Open 10:5, pages e036198.
Crossref
Crossref
Veronika Piskovatska, Kenneth B. Storey, Alexander M. Vaiserman & Oleh Lushchak. 2020. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders
319
332
.
Ragada El-Damanawi, Andrea K Viecelli, Elaine M Pascoe, Jonathan C Craig, David W Johnson, Andrew J Mallett, Carmel M Hawley & Thomas F Hiemstra. (2019) Metformin for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
V. V. Salukhov & B. V. Romashevsky. (2019) Modern aspects for preventive therapy of type 2 diabetes mellitus. Medical Council:4, pages 6-13.
Crossref
Crossref
Elena A. Christofides. (2019) Practical Insights Into Improving Adherence to Metformin Therapy in Patients With Type 2 Diabetes. Clinical Diabetes 37:3, pages 234-241.
Crossref
Crossref
Bo-Bae Seo, Mi-Ran Park & Soo-Chang Song. (2019) Sustained Release of Exendin 4 Using Injectable and Ionic-Nano-Complex Forming Polymer Hydrogel System for Long-Term Treatment of Type 2 Diabetes Mellitus. ACS Applied Materials & Interfaces 11:17, pages 15201-15211.
Crossref
Crossref
Lawrence Blonde, Susana Dipp & Daniel Cadena. (2018) Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations. Advances in Therapy 35:7, pages 939-965.
Crossref
Crossref
Lorraine Lipscombe, Gillian Booth, Sonia Butalia, Kaberi Dasgupta, Dean T. Eurich, Ronald Goldenberg, Nadia Khan, Lori MacCallum, Baiju R. Shah & Scot Simpson. (2018) Pharmacologic Glycemic Management of Type 2 Diabetes in Adults. Canadian Journal of Diabetes 42, pages S88-S103.
Crossref
Crossref
Nobuya Inagaki, Hiroki Sano, Yoshifumi Seki, Shingo Kuroda & Kohei Kaku. (2017) Efficacy and safety of once‐weekly oral trelagliptin switched from once‐daily dipeptidyl peptidase‐4 inhibitor in patients with type 2 diabetes mellitus: An open‐label, phase 3 exploratory study. Journal of Diabetes Investigation 9:2, pages 354-359.
Crossref
Crossref
Jennifer D Goldman. (2018) Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy. Clinical Medicine Insights: Endocrinology and Diabetes 11, pages 117955141878625.
Crossref
Crossref
Cristina Bianchi, Giuseppe Daniele, Angela Dardano & Stefano Del Prato. 2018. Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
527
569
.
Cristina Bianchi, Giuseppe Daniele, Angela Dardano & Stefano Del Prato. 2018. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
1
44
.
Lyudmila A. Ruyatkina & Dmitriy S. Ruyatkin. (2017) Multidimensional effects of metformin in patients with type 2 diabetes. Diabetes mellitus 20:3, pages 210-219.
Crossref
Crossref
Fabrice Bonnet & André Scheen. (2017) Understanding and overcoming metformin gastrointestinal intolerance. Diabetes, Obesity and Metabolism 19:4, pages 473-481.
Crossref
Crossref
Huang-tz Ou, Pei-Chi Chen & Meng-Hsing Wu. (2017) Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome. Journal of the Formosan Medical Association 116:2, pages 80-89.
Crossref
Crossref
Jaime A. Davidson & Lance Sloan. (2016) Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview. Advances in Therapy 34:1, pages 41-59.
Crossref
Crossref
G. Verstraete, P. Mertens, W. Grymonpré, P.J. Van Bockstal, T. De Beer, M.N. Boone, L. Van Hoorebeke, J.P. Remon & C. Vervaet. (2016) A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices. International Journal of Pharmaceutics 513:1-2, pages 602-611.
Crossref
Crossref
K. M. Dungan, R. Weitgasser, F. Perez Manghi, E. Pintilei, J. L. Fahrbach, H. H. Jiang, J. Shell & K. E. Robertson. (2016)
A 24‐week study to evaluate the efficacy and safety of once‐weekly dulaglutide added on to glimepiride in type 2 diabetes (
AWARD
‐8)
. Diabetes, Obesity and Metabolism 18:5, pages 475-482.
Crossref
Crossref
L. I. Igel, A. Sinha, K. H. Saunders, C. M. Apovian, D. Vojta & L. J. Aronne. (2016) Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity. Current Atherosclerosis Reports 18:4.
Crossref
Crossref
Mark A. MoyadMark A. Moyad. 2016. Integrative Medicine for Breast Cancer. Integrative Medicine for Breast Cancer
195
223
.
Yan-rong Ma, Zhi Rao, A-xi Shi, Ya-feng Wang, Jing Huang, Miao Han, Xin-dong Wang, Yong-wen Jin, Guo-qiang Zhang, Yan Zhou, Fan Zhang, Hong-yan Qin & Xin-an Wu. (2015) Simultaneous Determination of Metformin, Metoprolol and its Metabolites in Rat Plasma by LC–MS-MS: Application to Pharmacokinetic Interaction Study. Journal of Chromatographic Science, pages bmv097.
Crossref
Crossref
Susan L. Samson & Alan J. Garber. 2015. International Textbook of Diabetes Mellitus. International Textbook of Diabetes Mellitus
641
656
.
Antonio R. Chacra. (2014) Evolving Metformin Treatment Strategies in Type-2 Diabetes. American Journal of Therapeutics 21:3, pages 198-210.
Crossref
Crossref
Anthony H. Barnett, Bernard Charbonnel, Jia Li, Mark Donovan, Douglas Fleming & Nayyar Iqbal. (2013) Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy. Clinical Drug Investigation 33:10, pages 707-717.
Crossref
Crossref
N. Weiler, I. Thrun, M. Eberlin, D. Foltys, M. Heise, M. Hoppe-Lotichius, T. Zimmermann, I. Kraemer & G. Otto. (2013) Tacrolimus Effects and Side Effects After Liver Transplantation: Is There a Difference Between Immediate and Extended Release?. Transplantation Proceedings 45:6, pages 2321-2325.
Crossref
Crossref
James W. Little, Donald A. Falace, Craig S. Miller & Nelson L. Rhodus. 2013. Little and Falace's Dental Management of the Medically Compromised Patient. Little and Falace's Dental Management of the Medically Compromised Patient
219
239
.
R. R. Henry, A. V. Murray, M. H. Marmolejo, D. Hennicken, A. Ptaszynska & J. F. List. (2012) Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial. International Journal of Clinical Practice 66:5, pages 446-456.
Crossref
Crossref